Vc Thoughts, Health, Dna, Rna, Healthcare.
In a recent article, our team reviewed the growing promise of DNA and RNA-based therapies. Although prospects are limitless, as investors, we need to consider the inherent challenges facing scalability and widespread adoption of such technologies. Targeted delivery of DNA/RNA payloads requires